A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)

Clinical trial NCT01746862 · COMPLETED

Trial details

NCT number: NCT01746862
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Short Stature

Start date: 2012-12-01
Primary completion: 2014-08-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.